CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale SVP, GC & Corporate Secretary sold 2,500 shares at $23.62 ($59,046)
- 4 Open-market sale Senior Vice President, R&D sold 2,500 shares at $23.62 ($59,056)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at $23.61 ($177,071)
- 8-K Event Other events
- 4 Open-market sale Director sold 23,125 shares at an average $22.81 ($527,525)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement
- 4 Open-market sale Chief Commercial Officer sold 4,376 shares at an average $19.13 ($83,691)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Senior Vice President, R&D sold 1,500 shares at $18.48 ($27,720)
- 4 Open-market sale SVP, GC & Corporate Secretary sold 1,500 shares at $18.48 ($27,720)
- 4 Open-market sale Chief Medical Officer sold 750 shares at $18.48 ($13,860)
- 4 Open-market sale Chief Financial Officer sold 1,500 shares at $18.48 ($27,720)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 34 of 65 · 1,286 filings